AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
4min chapter
CAR T Cells and T-Cell Therapies for Cancer
JAMA Clinical Reviews
Understanding Risks and Durability of CAR T-Cell Therapies
This chapter examines the FDA's recent concerns about secondary malignancies linked to CAR T-cell therapies, focusing on both common and rare malignancies. It also explores ongoing research into the durability of treatment benefits and the implications for patients with extensive chemotherapy backgrounds.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode